The role of airway clearance treatments in CF patients on modulators
The role of airway clearance treatments in CF patients on modulators
Article:
Lancet Respir Med. 2023 Apr;11(4):329-340.
“Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials”
Reviewer: Dr. Paola Orozco